首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1624420

2024 年至 2031 年幹細胞檢測市場（按產品、檢測方法、應用和地區劃分）

Stem Cell Assay Market by Product, Assay, Application, & Region for 2024- 2031

出版日期: 2024年07月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年至 2031 年幹細胞檢測市場評估

對再生和個人化醫療的日益增長的需求是推動幹細胞檢測市場發展的因素之一。根據 Verified Market Research 分析師的預測，幹細胞檢測市場規模預計將在預測期內達到 78.1 億美元，到 2023 年將超過約 19.3 億美元。

幹細胞研究在毒理學和藥物發現的應用日益廣泛，也推動了幹細胞檢測市場的發展。 2024年至2031年的複合年增長率為19.07%。

幹細胞檢測市場定義/概述

幹細胞檢測是評估幹細胞特性和行為的實驗技術。在受控條件下對幹細胞進行測試，以確定其自我更新、分化為多種細胞類型以及增殖的能力。幹細胞檢測在生物醫學研究和再生醫學中發揮重要作用，其應用範圍包括藥物發現和開發到毒理學篩選和疾病建模。

此外，幹細胞檢測可透過確定潛在治療劑對幹細胞分化和功能的影響來幫助藥物開發。這些檢測方法也用於研究發育過程、篩檢藥物毒性以及研究癌症和神經系統疾病等疾病的病因。

哪些方面影響幹細胞檢測市場的成長？

主要的驅動力是幹細胞研究的不斷發展以及幹細胞分離、培養和分化方面的突破性研發。這些技術進步提高了幹細胞檢測的效率和有效性，使其在藥物研發、再生醫學和基礎研究等各種應用領域更具吸引力。 3D 細胞培養技術、高通量篩選方法等創新以及成像和分析工具的進步都在推動市場擴張。

人們對再生醫學的興趣日益濃厚，以及幹細胞治療心血管、神經和糖尿病等各種疾病的潛力，推動了對幹細胞檢測的需求。政府、企業和學術機構正在迅速投資幹細胞研究以探索治療應用，從而產生了對評估幹細胞療法的有效性和安全性的測試的需求。

此外，全球慢性病和遺傳疾病的增加使得開發新藥物和治療方法成為必要。幹細胞是產生此類療法的潛在選擇，推動了疾病建模、藥物開發和個人化醫療對幹細胞檢測的需求。隨著學術界和製藥公司致力於瞭解疾病原因並測試新的治療方法，對幹細胞檢測的需求也日益增長。

幹細胞檢測中的技術問題會影響市場成長嗎？

儘管幹細胞研究取得了進展，但如何有效將幹細胞分化為所需的細胞類型、如何保持幹細胞培養物的穩定性和純度以及如何使檢測方法在多個實驗室中可重複，仍是一個難題。這些課題影響了幹細胞檢測的可靠性和有效性，使得程序難以標準化和獲得一致的結果，並限制了市場擴張。

開發和實施幹細胞檢測需要在專門的設備、試劑和專業知識上進行大量投資。此類檢測的高成本對於資源有限的學術機構和中小企業來說是一個障礙。此外，幹細胞研究具有長期性，且幹細胞藥物的商業潛力存在不確定性，投資風險較大。這些財務障礙阻礙了幹細胞檢測業務的成長並限制了其擴張。

The growing need for regenerative therapies and personalized medicine is one factor propelling the stem cell assay market. According to the analyst from Verified Market Research, the stem cell assay market is estimated to reach a valuation of USD 7.81 Billion over the forecast period, surpassing around USD 1.93 Billion valued in 2023.

The growing use of stem cell research in toxicology and drug discovery is another factor propelling the market for stem cell assays. It enables the market to grow at a CAGR of 19.07% from 2024 to 2031.

Stem Cell Assay Market: Definition/Overview

A stem cell assay is a laboratory technique for assessing the properties and behavior of stem cells. It entails testing stem cells in controlled conditions to determine their ability to self-renew, differentiate into diverse cell types, and proliferate. Stem cell assays play an important role in biomedical research and regenerative medicine, with applications spanning from drug discovery and development to toxicological screening and disease modelling.

Furthermore, stem cell assays aid in drug development by determining the impact of prospective therapeutic drugs on stem cell differentiation and function. Also, these assays are utilized to research developmental processes, screen for pharmacological toxicities, and investigate disease causes such as cancer and neurological illnesses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Aspects Influencing the Growth of the Stem Cell Assay Market?

Continuous advancements in stem cell research, as well as the development of breakthrough methods for stem cell isolation, culturing, and differentiation, are key drivers. These technical advancements increase the efficiency and effectiveness of stem cell assays, making them more appealing for a variety of applications such as drug development, regenerative medicine, and fundamental research. Innovations such as 3D cell culture techniques, high-throughput screening methodologies, and advances in imaging and analytical tools all help to drive market expansion.

The growing interest in regenerative medicine, as well as the potential of stem cells to treat a variety of ailments such as cardiovascular disease, neurological disorders, and diabetes, is driving demand for stem cell assays. Governments, business companies, and academic institutions are rapidly investing in stem cell research to investigate therapeutic applications, creating a demand for tests used to assess the efficiency and safety of stem cell-based therapies.

Furthermore, the increasing global prevalence of chronic diseases and genetic disorders needs the development of new medicines and therapies. Stem cells represent a possible option for generating such treatments, increasing the demand for stem cell assays in disease modelling, drug development, and personalized medicine. The need for stem cell assays is increasing as academics and pharmaceutical companies work to better understand disease causes and test new treatments.

Will Technical Issues of Stem Cell Assay Impact the Growth of Market?

Despite advances in stem cell research, significant technical and scientific challenges remain, such as efficiently differentiating stem cells into desired cell types, maintaining the stability and purity of stem cell cultures, and ensuring assay reproducibility across multiple laboratories. These challenges have an impact on the reliability and effectiveness of stem cell assays, making it difficult to standardize techniques and generate consistent results, hence limiting market expansion.

Creating and running stem cell assays necessitates significant expenditure on specialised equipment, reagents, and expert personnel. The high costs of these assays represent a hurdle for academic institutions and small-to-medium businesses with limited resources. Furthermore, the long-term nature of stem cell research, as well as uncertainties about the commercial feasibility of stem cell-based medicines, represent major investment risks. These financial obstacles stymie the growth of the stem cell assay business, limiting its expansion.

Category-wise Acumens

What dynamics Contribute to the Dominance of Reagents and Kits Products?

According to VMR analyst, the reagents and kits segment is estimated to dominate the stem cell assay market during the forecast period. Reagents and kits are consumables used extensively in stem cell tests such as cell proliferation, differentiation, viability, and toxicity. Reagents and kits are in high demand due to their importance in daily laboratory operations and their recurrent nature. This need is being driven by continuous research and development efforts in both academic and commercial contexts, where stem cell assays are critical for drug discovery, therapeutic development, and basic research.

Reagents and kits are designed to meet a wide range of needs, from basic research to specific therapeutic areas. This versatility is strengthened by the ability to tailor kits to specific types of stem cells or tests. Such customization and application flexibility ensure that reagents and kits continue to be in high demand across a wide range of research areas and medicinal development projects, contributing to their market domination.

Furthermore, compared to instruments, which require significant initial capital investment and maintenance expenditures, reagents and kits are less expensive and more accessible to a larger range of customers, including small research labs and entrepreneurs. This decreased cost barrier promotes widespread adoption and continuing purchasing of reagents and kits, resulting in a bigger market share.

How do the Cytotoxicity Assays Influence the Growth Trajectory of the Market?

The viability or cytotoxicity assays segment is estimated to hold the largest share of the stem cell assay market during the forecast period. Viability or cytotoxicity assays are critical for determining the effects of medicines on cell health and survival, making them indispensable during the early stages of drug discovery and development. These tests assist evaluate the therapeutic index of drug candidates by analyzing their toxic effects on cells, making them critical in discovering possible treatments with the fewest cytotoxic effects.

Additionally, the expanding pharmaceutical and biotechnology companies' investment in new drug development fueling demand for these assays.

Furthermore, viability or cytotoxicity assays are versatile and can be used in a variety of research domains, including toxicology, cancer, and regenerative medicine. They are employed not just in stem cell research, but also in experiments with primary cells, cancer cells, and other cell lines. This broad applicability across several scientific and clinical sectors leads to their large market share.

Country/Region-wise Acumens

What are the Key Drivers Influencing the North American Stem Cell Assay Market?

North America is estimated to dominate the stem cell assay market during the forecast period. North America, particularly the United States, has a strong research and development infrastructure, with world-class universities, research institutions, and biotechnology and pharmaceutical corporations. This environment encourages innovation and enables ground-breaking research in stem cell technology and applications.

The presence of excellent research facilities and a highly skilled workforce facilitates the development, validation, and commercialization of stem cell assays, contributing considerably to the region's market leadership.

Furthermore, compared to other regions, North America, particularly the United States, offers a more favourable regulatory framework for stem cell research and therapeutic development. Regulatory authorities, such as the United States Food and Drug Administration (FDA), have created criteria and routes for the research and approval of stem cell-based medicines. This regulatory environment promotes innovation while maintaining safety and efficacy, making the region appealing to enterprises and researchers involved in the stem cell assay market.

What Factors Contribute to Surging Demand for Stem Cell Assays in the Asia Pacific?

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Many Asian Pacific countries have established major programs and financing schemes to encourage life science research and development, such as stem cell research and regenerative medicine. Governments in Japan, South Korea, China, and Australia are aggressively pushing stem cell research by providing direct money, establishing research centres, and forming collaborations with the commercial sector. These efforts aim to establish these countries as worldwide leaders in biotechnology and healthcare innovation, ultimately boosting the growth of the stem cell assay market.

Furthermore, Asia Pacific is experiencing an increase in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and neurological disorders, owing to an ageing population. This demographic transition raises the demand for novel cures and medical treatments, particularly those based on stem cell research. Stem cell assays are crucial in the development of these therapies because they facilitate drug discovery, toxicity testing, and disease mechanism comprehension, hence promoting regional market growth.

Competitive Landscape

The competitive landscape of the stem cell assay market is defined by a dynamic interaction of many elements, such as technological breakthroughs, R&D initiatives, regulatory frameworks, and strategic alliances. Furthermore, the presence of severe regulatory requirements for stem cell research and therapeutic development emphasizes the necessity of compliance and quality assurance, which increases market rivalry.

Some of the prominent players operating in the stem cell assay market include:

Thermo Fisher Scientific

Merck KGaA

Danaher

Becton, Dickinson and Company

Bio-Rad Laboratories

PerkinElmer

Agilent Technologies

Promega Corporation

Cell Biolabs

Miltenyi Biotec

STEMCELL Technologies

Bio-Techne Corporation

FUJIFILM Holdings Corporation

Sartorius Stedim Biotech

GE Healthcare

Roche Diagnostics

Latest Developments:

In February 2024, Thermo Fisher, a prominent market player, introduced an innovative serum-free stem cell culture medium that claims to promote stem cell multiplication and differentiation. This could be a huge advancement for companies developing stem cell medicines.

In February 2024, Danaher, another significant competitor, purchased a company that specializes in cell analysis technology. Danaher's position in the stem cell assay industry could be strengthened by this acquisition, which will provide improved stem cell characterization tools.

1 INTRODUCTION OF GLOBAL STEM CELL ASSAY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL STEM CELL ASSAY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL STEM CELL ASSAY MARKET, BY PRODUCT

5.1 Overview
5.2 Reagents and Kits
5.3 Instruments

6 GLOBAL STEM CELL ASSAY MARKET, BY APPLICATION

6.1 Overview
6.2 Regenerative Medicine and Therapy
6.3 Clinical Research
6.4 Drug Discovery and Development

7 GLOBAL STEM CELL ASSAY MARKET, BY ASSAY

7.1 Overview
7.2 Cell Identification Assays
7.3 Viability or Cytotoxicity Assays
7.4 Apoptosis Assays
7.5 Isolation & Purification Assays
7.6 Others

8 GLOBAL STEM CELL ASSAY MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL STEM CELL ASSAY MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Thermo Fisher Scientific
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Perkinelmer
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Stemcell Technologies
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Merck
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Bio-Rad Laboratories
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Agilent Technologies
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments